A novel DNA-binding protein modulating methicillin resistance in Staphylococcus aureus

Area of Science:

• Microbiology
• Genetics
• Molecular Biology

Background:

• Methicillin resistance in Staphylococcus aureus (MRSA) is primarily mediated by the mecA gene, encoding PBP2a.
• The influence of other genomic factors on MRSA resistance levels is not well understood.
• This study aimed to identify novel proteins interacting with the mec operator to uncover new regulators of methicillin resistance.

Purpose of the Study:

• To identify novel proteins that bind to the mec operator region in MRSA.
• To investigate the role of identified proteins in modulating methicillin resistance phenotypes.
• To elucidate the mechanism by which these factors influence resistance.

Main Methods:

• Protein-DNA binding assays using a DNA fragment containing the mec operator.
• Genetic manipulation (nonpolar deletion and complementation) of the identified gene in MRSA.
• Northern and Western blot analyses to assess gene transcription and protein levels.

Main Results:

• A novel helix-turn-helix DNA-binding protein, SA1665, was identified through its binding to the mec operator.
• Deletion of SA1665 increased methicillin resistance in a strain-dependent manner in heterogeneously resistant MRSA.
• SA1665 did not affect mecA transcription or PBP2a production levels.

Conclusions:

• SA1665 is a novel chromosomal factor influencing methicillin resistance in MRSA.
• Despite binding the mecA promoter, SA1665 does not directly alter mecA transcription or translation.
• SA1665 likely modulates MRSA resistance indirectly, potentially by regulating other genomic factors.